Low-Dose Aspirin Linked to 15% Lower Risk of Diabetes in Older Adults

SciTech
Sep 18, 2023

Low-Dose Aspirin Linked to 15% Lower Risk of Diabetes in Older Adults


New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) reveals that administering a daily dose of 100mg of aspirin can potentially reduce the risk of type 2 diabetes by 15% in individuals who are 65 years of age or older.

The authors, led by Professor Sophia Zoungas, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, emphasize that these findings highlight the need for deeper exploration into the role of anti-inflammatory agents like aspirin in diabetes prevention.